Real-time q-PCR and protein immunoblotting (Western blot) confirmed that CDC25B expression was significantly upregulated in cancer tissues compared with paracancerous tissues in clinical samples (Figures 1(d), 1(e), and 1(f)). This evidence concerns the gene CDC25B and cancer.